An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide.

Cedars-Sinai investigators have discovered a signaling interaction between two proteins in cells that controls fat ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...